Endo International plc: ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS

DUBLIN, May 5, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2022 and provided second-quarter 2022 financial

Related Keywords

Canada ,Dublin ,Ireland ,Canadian ,Blaise Coleman ,Prnewswire Endo International ,Branded Pharmaceuticals ,Company Net Debt Leverage Ratio ,Paladin Labs Inc ,Linkedin ,Generic Pharmaceuticals ,Endo Investor Relations Department ,Nasdaq ,Exchange Commission ,International Pharmaceuticals ,Pfizer Inc ,Endo International ,Nevakar Injectables Inc ,Company Loss ,Branded Specialty Products ,Chief Executive ,Months Ended March ,Diluted Net ,Continuing Operations ,Diluted Weighted Average Shares ,Diluted Net Income ,Adjusted Diluted Weighted Average Shares ,Adjusted Income ,Adjusted Diluted Net Income ,Sterile Injectables ,Specialty Products ,Note Regarding Forward Looking Statements ,Nevakar Injectables ,Operating Expenses ,Total Revenues ,Paladin Labs ,Condensed Consolidated Statement ,Condensed Consolidated Balance Sheet ,Cash Flow ,Qualified Settlement ,Current Report ,Supplemental Financial Information ,Condensed Consolidated Statements ,Net Debt Leverage Ratio ,Net Debt ,Restricted Cash ,Net Debt Leverage ,Debt Leverage Ratio ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Kendo ,Nternational ,Undo ,Reports ,First ,Quarter ,022 ,Financial ,Results ,